Bronchial Hyperreactivity Clinical Trial
Official title:
Diagnostic Utility of Different Airway Resistance Assessment Techniques in the Evaluation of Bronchial Hyperreactivity by Methacholine Challenge Testing
The aim of the study is to compare standard spirometric evaluation of methacholine challenge
test with plethysmographic, interrupter technique and forced oscillation technique (FOT)
evaluation of the airways resistance.
The study group will consist of patients referred for methacholine challenge test. All
patient will undergo spirometric, plethysmographic, interrupter technique and FOT
examinations - before and after inhalation of aerosols. Patients will also undergo the
measurement of nitric oxide concentration in exhaled air and laboratory tests, including:
blood count, measurement of serum C-reactive protein, sodium, potassium, creatinine,
immunoglobulin E and N-Terminal pro-brain natriuretic peptide (NT-proBNP) concentration.
The investigators intend to assess, if plethysmographic, and/or interrupter, and/or FOT
measurement of bronchial reactivity can replace standard spirometric assessment.
Plethysmography, interrupter technique and FOT are much more easier to perform for patients.
Furthermore, those two techniques are less dependent on patient's motivation and cooperation
ability. Thus, usage of FOT, interrupter technique and/or plethysmography in bronchial
hyperreactivity testing could make methacholine challenge test more comfortable and
available for more patients. The investigators are also going to analyze the relationship
between exhaled nitric oxide and functional indices of bronchial hyperreactivity.
Bronchial hyperreactivity is defined as the increased respiratory tract responsiveness to
multiple stimuli, which results in bronchial muscles constriction and bronchial lumen
narrowing. Bronchial hyperreactivity is a hallmark of asthma, however it may also be present
in other diseases, e.g. chronic obstructive pulmonary disease (COPD). Methacholine challenge
test is one of the bronchial reactivity assessment methods. Methacholine acts directly on
bronchial smooth muscles receptors and causes bronchoconstriction. Bronchial reactivity is
increased in the presence of active inflammation. Methacholine challenge testing is commonly
performed in patients with symptoms suggestive of asthma and negative result of spirometry
reversibility test. The measurement of methacholine concentration which causes 20% forced
expiratory volume at one second (FEV1) decrease in post-inhalation spirometry (PC20) is a
standard method of hyperreactivity evaluation. However, above method could be used among
patients who are able to perform acceptable spirometry. Furthermore, results of spirometry
might be influenced by level of compliance and motivation of patients. Moreover, whereas
spirometric methacholine challenge test has high negative predictive values, its positive
predictive value is relatively low. Thus, diagnostic utility of other pulmonary function
tests should be assessed in methacholine challenge test evaluation.
In plethysmography airway resistance is performed during tidal breathing. The increase of
specific airway resistance of 200% and the decrease of specific airway conductance of 40%
after methacholine inhalation, respectively, are proposed as a cut-off levels for bronchial
hyperreactivity diagnosis.
In forced oscillation technique (FOT), sinusoidal oscillations are emitted by membrane into
airway lumen and airway resistance is calculated on the basis of changes in air flow induced
by oscillations. The increase of resistance and decrease of reactance in FOT are typical for
bronchoconstriction.
Finally, also interrupter technique (IT) allows for airway resistance assessment during
tidal breathing. In IT, airway resistance is calculated on the basis of mouth pressure
measured directly after airway occlusion and airflow measured directly before occlusion.
The aim of the study is to compare standard spirometric evaluation of methacholine challenge
test with plethysmographic, interrupter technique and forced oscillation technique (FOT)
evaluation of the airways resistance.
All patient will undergo:
- clinical examination
- measurement of nitric oxide concentration in exhaled air
- spirometric, plethysmographic, interrupter technique and FOT examinations - before
inhalation and after inhalation of aerosols
- following laboratory tests: blood count, measurement of serum C-reactive protein (CRP),
sodium, potassium, creatinine, immunoglobulin E and NT-proBNP concentration
Patients will be provided with written and spoken information about study protocol. Written
informed consent will be obtained from every patient.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06016244 -
Safe, Effective and Cost-Effective Oxygen Saturation Targets for Children and Adolescents With Respiratory Distress: a Randomized Controlled Trial
|
N/A | |
Completed |
NCT01654588 -
Different End Points for Bronchial Hyperactivity (BHR) Tests.
|
N/A | |
Completed |
NCT00916526 -
Measurement of Exhaled Nitric Oxide (NO) and Bronchial Provocation Test With Mannitol as a Predictor of Response to Inhaled Corticosteroids in Chronic Cough
|
N/A | |
Not yet recruiting |
NCT06034145 -
Methacholine Challenge Testing: Comparison of FEV1 and IOS Parameters in Adult Asthma Patients
|
||
Recruiting |
NCT05618769 -
Towards Life-Long Healthy Lungs: A Multidisciplinary Follow-up Framework for Preterm Infants
|
N/A | |
Completed |
NCT05821868 -
Contrasting Dosivent With Plus Flow Vu Spacer in Bronchial Hyperreactivity Participants
|
N/A | |
Completed |
NCT00503659 -
Comparison of Two Methods of Bronchial Methacholine Provocation
|
N/A | |
Not yet recruiting |
NCT04168554 -
Telemedicine in the Generals Practitioners Office
|
||
Completed |
NCT00453765 -
The Effect of Montelukast in Patients With Chronic Cough and Bronchial Hyperreactivity
|
Phase 4 | |
Terminated |
NCT00567463 -
Early Antiinflammatory Treatment of Asthma
|
N/A | |
Completed |
NCT01269528 -
Prospective Evaluation of the Efficacy of Palivizumab Administration in Children Born at 29-32 Weeks of Gestation
|
N/A | |
Completed |
NCT00519740 -
Influence of Nutrition on Nasal and Bronchial Affliction in Patients With Allergy on Grass-Pollen
|
N/A | |
Recruiting |
NCT06110481 -
Reversibility of Bronchial Obstruction in Children Born Preterm
|